论文信息 - Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis. - 字舞流文

Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.

H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Manshouri | A. Quintás-Cardama | S. Verstovsek | F. Ravandi | C. Bueso-Ramos | Deborah A. Thomas | A. Ferrajoli | D. Thomas | C. Bueso‐Ramos | A. Quintás-Cardama